Please be aware that the information provided is a summary of select releases made to the ASX, as evaluated and interpreted by ASX Briefs. It is important to thoroughly read the entire original release before forming an opinion, rather than relying solely on the brief overview presented here. ASX Briefs is not associated with the ASX. ASX Briefs is an experimental AI project incorporating chatGPT, and as such, does not guarantee the accuracy of the information provided.
Atomo Diagnostics Limited has secured a purchase order from Newfoundland Diagnostics Limited worth around A$900,000.
Newfoundland is an emerging leader in the European diagnostic self-test market, with extensive distribution networks.
Atomo and Newfoundland anticipate that this purchase order for HIV Self-Tests will be the first of many and are working to rapidly conclude a comprehensive agreement for supply of Atomo’s products to Newfoundland for Europe.